| Stock | PriceCurrent trading price. | Market CapTotal market capitalization. | FKPrice to Earnings ratio. | PD/DDPrice to Book ratio. | EV/EBITDAEnterprise Value / EBITDA. | ROICReturn on Invested Capital. | WACCWeighted Average Cost of Capital (WACC). | PUSLAFinancial health score (0-100). | DamodaranValuation score. | Intrinsic ValueFair value via DCF model. | Potential %Expected upside potential %. | Dalio RiskDalio Debt Cycle Score | Debt/EquityDebt to Equity ratio. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EZTC3
|
11.90 | 3.3B | 5.89 | 0.64 | 6.65 | 5.0% | 14.5% | 72 | 48 | 24.22 | +71.4% | 70 | 0.34 |
|
MRVE3
|
5.51 | 3.1B | — | 0.59 | 33.59 | 6.8% | 5.4% | 65 | 63 | 12.49 | +81.1% | 41 | 1.61 |
|
CYRE3
|
24.29 | 8.9B | 4.50 | 0.84 | 5.30 | 6.5% | 12.8% | 62 | 41 | 36.05 | +31.0% | 65 | 0.83 |
|
MULT3
|
27.92 | 8.4B | 6.30 | 1.30 | 6.05 | 16.0% | 17.1% | 62 | 45 | 33.07 | +11.8% | 62 | 0.84 |
|
ALOS3
|
26.69 | 13.3B | 16.12 | 1.03 | 7.78 | 4.5% | 14.6% | 58 | 41 | 34.56 | +18.9% | 62 | 0.47 |
|
IGTI11
|
24.53 | 29.5B | 37.42 | 6.06 | 24.07 | 12.3% | 16.6% | 36 | 24 | 7.19 | -39.6% | 73 | 0.81 |
The Lothien health scores and analyses on this page are for informational purposes only. They do not constitute investment advice. Please consult a licensed investment advisor before making investment decisions.